does transdermal buprenorphine patch provide pain relief following surgical third molar extraction?

Evaluation of analgesic efficacy of transdermal buprenorphine patch following surgical third molar extraction- a prospective clinical study - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099960

Enrollment

Registered

2025-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Buprenorphine patch: Buprenorphine patch to be given and need for rescue medication to be checked along with analgesic efficacy of patch via VAS scale 50mcg patch to be given once after

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18- 50 years of age. 2. No systemic co morbidities. 3. Indicated for surgical extraction of a third molar. 4. Patients who have not have been administered painkillers prior to the procedure. 5. Patients willing to consent and participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients below the ages of 18 and above 50. 2. Systemic co morbidities. 3. Pregnant/ Lactating women. 4. Patients not willing to participate in the study.

Design outcomes

Primary

Measure	Time frame
Buprenorphine is expected to provide greater relief from pain , owing to its longer duration of action and ceiling effect. Timepoint: 1,12,24 and 48 hours	—

Secondary

Measure	Time frame
NILTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Aditya Jape

Dr D Y Patil Dental College and Hospital Pimpri Pune

uday.londhe@dpu.edu.in9637467689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026